Ann: FTT enters agreement- Veterinary Medical Technology Pipeline, page-58

I think it will pass.

I don't think the tax losses will be able to be utilised even if it was bio. As you say, it is narrow and the business would probably need to be in wound care a la Avita or something to use those losses.

I don't see any issues with the 4 months. That is normal with deals like this. They had to suspend it as it looked like the trading indicated people may have known something was afoot. So the right thing to do.

My issue is whether the ASX will allow it. I think SUD had an issue when their chairman wanted to do a transformative deal in bio and ASX rejected it.